Get started
Author

Hai‐Juan Bao

SNORA70E promotes the occurrence and development of ovarian cancer through pseudouridylation modification of RAP1B and alternative splicing of PARPBP
2022 · Shuo Chen, Qian‐hui Li, et al. · Journal of Cellular and Molecular Medicine · 42
Pyroptosis and inflammasomes in cancer and inflammation
2023 · Jie‐Lin Wang, Sheng‐Ni Hua, et al. · MedComm · 40
PDF
Box C/D snoRNA SNORD89 influences the occurrence and development of endometrial cancer through 2’-O-methylation modification of Bim
2022 · Hai-juan Bao, Xi Chen, et al. · Cell Death Discovery · 38
PDF
Biological roles of A-to-I editing: implications in innate immunity, cell death, and cancer immunotherapy
2023 · Jing Yuan, Li Xu, et al. · Journal of Experimental & Clinical Cancer Research · 32
PDF
SNORD60 promotes the tumorigenesis and progression of endometrial cancer through binding PIK3CA and regulating PI3K/AKT/mTOR signaling pathway
2022 · Wu Wu, Xi Chen, et al. · Molecular Carcinogenesis · 15
piR-26441 inhibits mitochondrial oxidative phosphorylation and tumorigenesis in ovarian cancer through m6A modification by interacting with YTHDC1
2025 · Jing Yuan, Bu-Min Xie, et al. · Cell Death and Disease · 12
PDF
Role and Mechanism of Epigenetic Regulation in the Aging of Germ Cells: Prospects for Targeted Interventions
2024 · Xiang-Chun Huang, Yi-Nan Jiang, et al. · Aging and Disease · 10
PDF
WNT6 participates in the occurrence and development of ovarian cancer by upregulating/activating the typical Wnt pathway and Notch1 signaling pathway
2022 · Haijuan Bao, Wu Wu, et al. · Gene · 9
SNORD99 promotes endometrial cancer development by inhibiting GSDMD ‐mediated pyroptosis through 2'‐O‐methylation modification
2024 · Jing‐yuan Xian, Wu Wu, et al. · Journal of Cellular and Molecular Medicine · 8
SNORD9 promotes ovarian cancer tumorigenesis via METTL3/IGF2BP2-mediated NFYA m6A modification and is a potential target for antisense oligonucleotide therapy
2025 · Shuo Chen, Jing-Tao Wen, et al. · Life Sciences · 6
Causal relationship between 91 circulating inflammatory proteins and gynecological diseases: A two-sample bidirectional Mendelian randomization study
2025 · Jie-Lin Wang, Ping-An Zhang, et al. · International Journal of Biological Macromolecules · 4
PiR-26681: A Promising Therapeutic Inhibitor Targeting METTL3/METTL14 Complex-Mediated FBXO16 M6A Modification and Suppressing the EMT/WNT Pathway in Ovarian Cancer
2024 · Shuo Chen, Jie-lin Wang, et al. · Research Square · 1
rsRNA-28S-21 promotes endometrial cancer by regulating ferroptosis through the NSUN5-FTH1/FTL pathway
2026 · Yao Liu, Jing-yuan Xian, et al. · Gene
piR-26681 suppresses ovarian cancer progression by enhancing METTL3/METTL14-mediated m6A modification of FBXO16 and impairing DNA repair via MORF4L1 degradation
2026 · Jie-Lin Wang, Qing-Hua Wu, et al. · Cellular & Molecular Biology Letters
Additional file 3 of piR-26681 suppresses ovarian cancer progression by enhancing METTL3/METTL14-mediated m6A modification of FBXO16 and impairing DNA repair via MORF4L1 degradation
2026 · Jie-Lin Wang, Qing-Hua Wu, et al. · Figshare
Additional file 2 of piR-26681 suppresses ovarian cancer progression by enhancing METTL3/METTL14-mediated m6A modification of FBXO16 and impairing DNA repair via MORF4L1 degradation
2026 · Jie-Lin Wang, Qing-Hua Wu, et al. · Figshare
Additional file 1 of piR-26681 suppresses ovarian cancer progression by enhancing METTL3/METTL14-mediated m6A modification of FBXO16 and impairing DNA repair via MORF4L1 degradation
2026 · Jie-Lin Wang, Qing-Hua Wu, et al. · Figshare
RAB30 Intron-Derived Box H/ACA snoRNA SNORA70E Promotes the Occurrence and Development of Epithelial Ovarian Cancer Through Pseudouridylation Modification of RAP1B and Alternative Splicing of PARPBP
2021 · Shuo Chen, Xi Chen, et al. · SSRN Electronic Journal
Works count: 18
Citation count: 217
H-index: 8
I10-index: 7
Year
Topic
Type